Skip to main content
INSMED Inc logo

INSMED Inc — Investor Relations & Filings

Ticker · INSM ISIN · US4576693075 LEI · 529900Q55QAG41CCAC11 US Manufacturing
Open in API
Filings indexed 1,323 across all filing types
Latest filing 2020-04-30 Interim / Quarterly Rep…
Country US United States of America
Listing US INSM

About INSMED Inc

https://insmed.com/

Insmed Incorporated is a global biopharmaceutical company dedicated to developing and commercializing therapies for patients with serious and rare diseases. The company's primary focus is on addressing areas of high unmet medical need. Its marketed product, Arikayce (liposomal amikacin for inhalation), is a treatment for Mycobacterium avium complex (MAC) lung disease. Insmed leverages proprietary technologies, such as its advanced liposomal pulmonary delivery system, to create novel treatments. The company maintains a diverse pipeline of investigational medicines and is actively advancing potential new therapies through various stages of clinical trials.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q1 2020
2020-04-30 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce significant events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and references a press release regarding financial results for the quarter ended March 31, 2020. The document includes a press release as an exhibit but does not contain detailed financial statements or comprehensive analysis itself. The length is 3653 characters, which is relatively short and consistent with a current report or earnings release announcement. The document is not the full earnings release but a filing that furnishes the press release. According to the rules, if the document is short and primarily announces or furnishes a press release of financial results, it should be classified as an Earnings Release (ER). The presence of financial results for a quarter and the press release indicates this is an Earnings Release filing rather than a full Interim Report (IR) or Annual Report (10-K). Therefore, the best classification is Earnings Release (ER).
2020-04-30 English
4
Director's Dealing
2020-04-02 English
3
Director's Dealing
2020-04-02 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details the appointment of a new board member, Ms. Carol A. Schafer, including her background, role, and compensation. This fits the description of announcements related to changes in the company's board of directors or senior management. There are no financial statements or detailed financial performance data present, so it is not an Annual Report (10-K) or Interim Report (IR). The document is not a proxy statement, earnings release, or other categories. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length and detail support a high confidence score.
2020-04-02 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes information about the upcoming Annual Meeting of shareholders, voting instructions, and details about the items to be voted on, such as election of directors, advisory vote on executive compensation, ratification of auditors, and approval of an incentive plan amendment. The document is not the proxy statement itself but additional definitive materials related to the proxy. The content focuses on soliciting shareholder votes and providing proxy materials, which aligns with the definition of Proxy Solicitation & Information Statement (PSI). The document length (6338 characters) and content confirm it is not a full annual report or earnings release but a proxy solicitation document.
2020-03-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.